HHS - Health Dept Decision To Move Cannabis To Lower-Risk Category: Bull Case Narrative For The Industry | Benzinga
Recent news that the Department of Health and Human Services (HHS) is recommending the reclassification of marijuana as a Schedule III drug under the Controlled Substances Act has ignited significant market reactions.
On the day following the report, MSOS ETF (ARCA: MSOS) surged 21%. Notable companies also experienced remarkable gains, with State House Holdings Inc. (OTC: STHZF) skyrocketing by 74%, Columbia Care (OTC: CCHWF) witnessing a 38% boost, Jushi (OTC: JUSH) rising by 32% and Ayr Wellness (OTC: AYRWF) showing a 29% increase.
Analysis firm Zuanic & Associates (Z&A), in a recent report, says the news is a potentially game-changing development.
Delve Deeper into Cannabis Regulation at the Benzinga Cannabis Capital Conference in Chicago on September 27-28. Connect with Z&A's Pablo Zuanic and engage in discussions about the recent Biden Administration's recommendation on cannabis regulation.
Navigating Regulatory Shifts: A Bullish Outlook Amid Uncertainties
The report presents an optimistic "bull case narrative" for the industry, and argues ...